1.18
|
1.29e-28
|
GO:0050794
|
regulation of cellular process
|
1.17
|
5.64e-27
|
GO:0050789
|
regulation of biological process
|
1.16
|
1.40e-26
|
GO:0065007
|
biological regulation
|
1.29
|
2.30e-21
|
GO:0048731
|
system development
|
1.24
|
1.28e-19
|
GO:0032502
|
developmental process
|
1.25
|
1.38e-19
|
GO:0007275
|
multicellular organismal development
|
1.26
|
3.97e-19
|
GO:0048856
|
anatomical structure development
|
1.40
|
2.68e-18
|
GO:0007399
|
nervous system development
|
1.09
|
3.19e-18
|
GO:0009987
|
cellular process
|
1.22
|
8.30e-17
|
GO:0023052
|
signaling
|
1.28
|
1.49e-16
|
GO:0048522
|
positive regulation of cellular process
|
1.27
|
2.57e-16
|
GO:0048518
|
positive regulation of biological process
|
1.30
|
9.77e-16
|
GO:0048523
|
negative regulation of cellular process
|
1.36
|
2.39e-15
|
GO:0009653
|
anatomical structure morphogenesis
|
1.28
|
2.59e-15
|
GO:0048519
|
negative regulation of biological process
|
1.37
|
3.23e-15
|
GO:0009966
|
regulation of signal transduction
|
1.35
|
3.24e-15
|
GO:0023051
|
regulation of signaling
|
1.22
|
2.20e-14
|
GO:0007165
|
signal transduction
|
1.29
|
6.84e-14
|
GO:0030154
|
cell differentiation
|
1.29
|
9.63e-14
|
GO:0048869
|
cellular developmental process
|
1.44
|
8.39e-13
|
GO:0022008
|
neurogenesis
|
1.29
|
2.33e-12
|
GO:0048583
|
regulation of response to stimulus
|
1.39
|
1.65e-11
|
GO:0010646
|
regulation of cell communication
|
1.18
|
1.68e-11
|
GO:0051716
|
cellular response to stimulus
|
1.59
|
2.02e-11
|
GO:0072358
|
cardiovascular system development
|
1.59
|
2.02e-11
|
GO:0072359
|
circulatory system development
|
1.40
|
2.46e-11
|
GO:0006357
|
regulation of transcription from RNA polymerase II promoter
|
1.36
|
7.59e-11
|
GO:0010604
|
positive regulation of macromolecule metabolic process
|
1.42
|
9.24e-11
|
GO:0048699
|
generation of neurons
|
1.40
|
1.15e-10
|
GO:0050793
|
regulation of developmental process
|
1.45
|
1.38e-09
|
GO:0045595
|
regulation of cell differentiation
|
1.43
|
1.81e-09
|
GO:2000026
|
regulation of multicellular organismal development
|
1.32
|
1.99e-09
|
GO:0051239
|
regulation of multicellular organismal process
|
1.69
|
2.11e-09
|
GO:0001944
|
vasculature development
|
1.33
|
2.32e-09
|
GO:0031325
|
positive regulation of cellular metabolic process
|
1.45
|
3.54e-09
|
GO:0010628
|
positive regulation of gene expression
|
1.41
|
3.59e-09
|
GO:0051173
|
positive regulation of nitrogen compound metabolic process
|
1.32
|
3.70e-09
|
GO:0009893
|
positive regulation of metabolic process
|
1.41
|
7.94e-09
|
GO:0045935
|
positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.17
|
8.86e-09
|
GO:0080090
|
regulation of primary metabolic process
|
1.51
|
9.93e-09
|
GO:0000904
|
cell morphogenesis involved in differentiation
|
1.18
|
1.34e-08
|
GO:0060255
|
regulation of macromolecule metabolic process
|
1.46
|
2.58e-08
|
GO:0000902
|
cell morphogenesis
|
1.17
|
3.07e-08
|
GO:0031323
|
regulation of cellular metabolic process
|
1.68
|
4.24e-08
|
GO:0001568
|
blood vessel development
|
1.35
|
4.78e-08
|
GO:0032879
|
regulation of localization
|
1.44
|
4.86e-08
|
GO:0032989
|
cellular component morphogenesis
|
1.38
|
5.53e-08
|
GO:0051128
|
regulation of cellular component organization
|
1.42
|
6.23e-08
|
GO:0051254
|
positive regulation of RNA metabolic process
|
1.44
|
6.31e-08
|
GO:0045893
|
positive regulation of transcription, DNA-dependent
|
1.15
|
1.05e-07
|
GO:0019222
|
regulation of metabolic process
|
1.35
|
1.07e-07
|
GO:0048468
|
cell development
|
1.23
|
2.13e-07
|
GO:0048513
|
organ development
|
1.34
|
2.90e-07
|
GO:0042127
|
regulation of cell proliferation
|
1.16
|
3.78e-07
|
GO:0016043
|
cellular component organization
|
1.59
|
4.34e-07
|
GO:0060284
|
regulation of cell development
|
1.36
|
5.19e-07
|
GO:0031328
|
positive regulation of cellular biosynthetic process
|
1.38
|
5.43e-07
|
GO:0010557
|
positive regulation of macromolecule biosynthetic process
|
1.47
|
1.14e-06
|
GO:0045944
|
positive regulation of transcription from RNA polymerase II promoter
|
1.16
|
1.23e-06
|
GO:0071840
|
cellular component organization or biogenesis
|
1.40
|
1.69e-06
|
GO:0007167
|
enzyme linked receptor protein signaling pathway
|
1.12
|
1.91e-06
|
GO:0032501
|
multicellular organismal process
|
1.34
|
2.33e-06
|
GO:0009888
|
tissue development
|
1.34
|
3.01e-06
|
GO:0009891
|
positive regulation of biosynthetic process
|
1.37
|
3.51e-06
|
GO:0009790
|
embryo development
|
1.61
|
4.19e-06
|
GO:0045596
|
negative regulation of cell differentiation
|
1.37
|
4.22e-06
|
GO:0030182
|
neuron differentiation
|
1.12
|
4.84e-06
|
GO:0043170
|
macromolecule metabolic process
|
1.44
|
6.90e-06
|
GO:0031175
|
neuron projection development
|
1.46
|
9.48e-06
|
GO:0048812
|
neuron projection morphogenesis
|
1.43
|
1.08e-05
|
GO:0032990
|
cell part morphogenesis
|
1.38
|
1.28e-05
|
GO:0030030
|
cell projection organization
|
1.43
|
1.49e-05
|
GO:0048858
|
cell projection morphogenesis
|
1.42
|
1.84e-05
|
GO:0009967
|
positive regulation of signal transduction
|
1.45
|
1.88e-05
|
GO:0051094
|
positive regulation of developmental process
|
1.41
|
1.94e-05
|
GO:0023056
|
positive regulation of signaling
|
1.45
|
2.28e-05
|
GO:0048667
|
cell morphogenesis involved in neuron differentiation
|
1.46
|
2.45e-05
|
GO:0009968
|
negative regulation of signal transduction
|
1.55
|
2.51e-05
|
GO:0051270
|
regulation of cellular component movement
|
1.12
|
2.57e-05
|
GO:0044260
|
cellular macromolecule metabolic process
|
1.40
|
3.24e-05
|
GO:0010647
|
positive regulation of cell communication
|
1.45
|
3.80e-05
|
GO:0007409
|
axonogenesis
|
1.44
|
3.80e-05
|
GO:0023057
|
negative regulation of signaling
|
1.58
|
3.90e-05
|
GO:0030334
|
regulation of cell migration
|
1.63
|
4.35e-05
|
GO:0048514
|
blood vessel morphogenesis
|
1.57
|
4.41e-05
|
GO:2000145
|
regulation of cell motility
|
1.16
|
4.50e-05
|
GO:0051171
|
regulation of nitrogen compound metabolic process
|
1.31
|
4.70e-05
|
GO:0006351
|
transcription, DNA-dependent
|
1.44
|
4.74e-05
|
GO:0010648
|
negative regulation of cell communication
|
1.17
|
4.86e-05
|
GO:0019219
|
regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.09
|
5.55e-05
|
GO:0044238
|
primary metabolic process
|
1.38
|
5.77e-05
|
GO:0048666
|
neuron development
|
1.17
|
6.62e-05
|
GO:0010468
|
regulation of gene expression
|
1.40
|
6.66e-05
|
GO:0007169
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
1.43
|
7.63e-05
|
GO:0032583
|
regulation of gene-specific transcription
|
1.53
|
8.14e-05
|
GO:0040012
|
regulation of locomotion
|
1.51
|
9.60e-05
|
GO:0001501
|
skeletal system development
|
1.16
|
1.08e-04
|
GO:0031326
|
regulation of cellular biosynthetic process
|
1.17
|
1.12e-04
|
GO:2000112
|
regulation of cellular macromolecule biosynthetic process
|
1.31
|
1.20e-04
|
GO:0048584
|
positive regulation of response to stimulus
|
1.27
|
1.26e-04
|
GO:0051246
|
regulation of protein metabolic process
|
1.27
|
1.35e-04
|
GO:0032268
|
regulation of cellular protein metabolic process
|
1.49
|
1.74e-04
|
GO:0051093
|
negative regulation of developmental process
|
1.29
|
2.53e-04
|
GO:0008219
|
cell death
|
1.60
|
2.62e-04
|
GO:0043193
|
positive regulation of gene-specific transcription
|
1.45
|
2.77e-04
|
GO:0009792
|
embryo development ending in birth or egg hatching
|
1.16
|
2.88e-04
|
GO:0009889
|
regulation of biosynthetic process
|
2.01
|
3.64e-04
|
GO:0022612
|
gland morphogenesis
|
1.45
|
3.82e-04
|
GO:0043009
|
chordate embryonic development
|
2.13
|
4.19e-04
|
GO:0090101
|
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway
|
1.29
|
4.49e-04
|
GO:0016265
|
death
|
1.33
|
4.78e-04
|
GO:0042325
|
regulation of phosphorylation
|
1.32
|
5.49e-04
|
GO:0019220
|
regulation of phosphate metabolic process
|
1.32
|
5.49e-04
|
GO:0051174
|
regulation of phosphorus metabolic process
|
1.15
|
5.61e-04
|
GO:0071842
|
cellular component organization at cellular level
|
1.28
|
6.50e-04
|
GO:0040011
|
locomotion
|
1.77
|
6.79e-04
|
GO:0090092
|
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway
|
1.16
|
6.97e-04
|
GO:0010556
|
regulation of macromolecule biosynthetic process
|
1.34
|
7.90e-04
|
GO:0009887
|
organ morphogenesis
|
1.19
|
9.62e-04
|
GO:0006464
|
protein modification process
|
1.35
|
1.23e-03
|
GO:0006928
|
cellular component movement
|
1.33
|
1.29e-03
|
GO:2000113
|
negative regulation of cellular macromolecule biosynthetic process
|
1.40
|
1.33e-03
|
GO:0008285
|
negative regulation of cell proliferation
|
1.36
|
1.36e-03
|
GO:0045892
|
negative regulation of transcription, DNA-dependent
|
1.08
|
1.41e-03
|
GO:0008152
|
metabolic process
|
1.32
|
1.63e-03
|
GO:0001932
|
regulation of protein phosphorylation
|
1.42
|
1.73e-03
|
GO:0010551
|
regulation of gene-specific transcription from RNA polymerase II promoter
|
1.49
|
1.92e-03
|
GO:0035295
|
tube development
|
1.33
|
1.93e-03
|
GO:0042060
|
wound healing
|
1.20
|
2.07e-03
|
GO:0065009
|
regulation of molecular function
|
1.31
|
2.14e-03
|
GO:0010558
|
negative regulation of macromolecule biosynthetic process
|
1.30
|
2.37e-03
|
GO:0009890
|
negative regulation of biosynthetic process
|
1.16
|
2.37e-03
|
GO:0065008
|
regulation of biological quality
|
1.28
|
2.53e-03
|
GO:0031399
|
regulation of protein modification process
|
1.37
|
2.57e-03
|
GO:0048646
|
anatomical structure formation involved in morphogenesis
|
1.29
|
2.77e-03
|
GO:0051049
|
regulation of transport
|
1.32
|
2.81e-03
|
GO:0010629
|
negative regulation of gene expression
|
1.08
|
2.85e-03
|
GO:0044237
|
cellular metabolic process
|
1.34
|
2.88e-03
|
GO:0051253
|
negative regulation of RNA metabolic process
|
1.35
|
2.91e-03
|
GO:0007417
|
central nervous system development
|
1.30
|
2.92e-03
|
GO:0031327
|
negative regulation of cellular biosynthetic process
|
1.45
|
2.95e-03
|
GO:0022603
|
regulation of anatomical structure morphogenesis
|
1.25
|
3.25e-03
|
GO:0032774
|
RNA biosynthetic process
|
1.14
|
5.02e-03
|
GO:0071841
|
cellular component organization or biogenesis at cellular level
|
1.56
|
5.12e-03
|
GO:0048732
|
gland development
|
1.35
|
5.31e-03
|
GO:0048585
|
negative regulation of response to stimulus
|
1.13
|
5.48e-03
|
GO:0019538
|
protein metabolic process
|
2.90
|
6.21e-03
|
GO:0048008
|
platelet-derived growth factor receptor signaling pathway
|
1.53
|
6.71e-03
|
GO:0001701
|
in utero embryonic development
|
1.15
|
7.42e-03
|
GO:0051252
|
regulation of RNA metabolic process
|
1.51
|
7.77e-03
|
GO:0002009
|
morphogenesis of an epithelium
|
2.32
|
8.39e-03
|
GO:0030512
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
1.90
|
8.42e-03
|
GO:2000027
|
regulation of organ morphogenesis
|
2.06
|
9.54e-03
|
GO:0060348
|
bone development
|
1.14
|
9.82e-03
|
GO:0044267
|
cellular protein metabolic process
|
1.59
|
1.04e-02
|
GO:0010552
|
positive regulation of gene-specific transcription from RNA polymerase II promoter
|
1.59
|
1.04e-02
|
GO:0051272
|
positive regulation of cellular component movement
|
1.41
|
1.24e-02
|
GO:0045597
|
positive regulation of cell differentiation
|
1.43
|
1.28e-02
|
GO:0048729
|
tissue morphogenesis
|
1.15
|
1.32e-02
|
GO:0006355
|
regulation of transcription, DNA-dependent
|
1.17
|
1.45e-02
|
GO:0007166
|
cell surface receptor linked signaling pathway
|
1.16
|
1.50e-02
|
GO:0043412
|
macromolecule modification
|
1.47
|
1.51e-02
|
GO:0050767
|
regulation of neurogenesis
|
1.39
|
1.55e-02
|
GO:0007420
|
brain development
|
1.43
|
1.59e-02
|
GO:0051130
|
positive regulation of cellular component organization
|
1.30
|
1.74e-02
|
GO:0009725
|
response to hormone stimulus
|
1.16
|
1.76e-02
|
GO:0010467
|
gene expression
|
1.37
|
1.78e-02
|
GO:0007264
|
small GTPase mediated signal transduction
|
1.27
|
1.88e-02
|
GO:0012501
|
programmed cell death
|
1.24
|
1.97e-02
|
GO:0010605
|
negative regulation of macromolecule metabolic process
|
2.38
|
1.98e-02
|
GO:0061035
|
regulation of cartilage development
|
1.55
|
2.03e-02
|
GO:0030900
|
forebrain development
|
1.30
|
2.15e-02
|
GO:0050878
|
regulation of body fluid levels
|
1.43
|
2.36e-02
|
GO:0051960
|
regulation of nervous system development
|
1.29
|
2.36e-02
|
GO:0051172
|
negative regulation of nitrogen compound metabolic process
|
1.58
|
2.38e-02
|
GO:0040017
|
positive regulation of locomotion
|
1.59
|
2.49e-02
|
GO:0030335
|
positive regulation of cell migration
|
1.59
|
2.49e-02
|
GO:2000147
|
positive regulation of cell motility
|
1.34
|
2.79e-02
|
GO:0008283
|
cell proliferation
|
1.32
|
2.87e-02
|
GO:0007599
|
hemostasis
|
1.42
|
2.97e-02
|
GO:0030029
|
actin filament-based process
|
1.37
|
2.97e-02
|
GO:0051056
|
regulation of small GTPase mediated signal transduction
|
1.29
|
3.01e-02
|
GO:0045934
|
negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.26
|
3.03e-02
|
GO:0007267
|
cell-cell signaling
|
1.22
|
3.07e-02
|
GO:0006793
|
phosphorus metabolic process
|
1.22
|
3.07e-02
|
GO:0006796
|
phosphate metabolic process
|
1.27
|
3.38e-02
|
GO:0009719
|
response to endogenous stimulus
|
1.26
|
3.45e-02
|
GO:0006915
|
apoptosis
|
1.19
|
3.54e-02
|
GO:0035556
|
intracellular signal transduction
|
1.46
|
3.67e-02
|
GO:0007507
|
heart development
|
2.16
|
3.74e-02
|
GO:0060349
|
bone morphogenesis
|
1.36
|
3.81e-02
|
GO:0000122
|
negative regulation of transcription from RNA polymerase II promoter
|
1.55
|
4.04e-02
|
GO:0001525
|
angiogenesis
|
1.93
|
4.06e-02
|
GO:0048634
|
regulation of muscle organ development
|
1.42
|
4.25e-02
|
GO:0061061
|
muscle structure development
|
1.22
|
4.67e-02
|
GO:0009892
|
negative regulation of metabolic process
|
1.58
|
4.76e-02
|
GO:0045165
|
cell fate commitment
|